Fujifilm Pharmaceuticals U.s.a., Inc.

This early-stage study aims to determine the safety and appropriate dosage of a new experimental cancer drug called FF-10850. The trial will enroll approximately 96 adults with advanced solid tumors that have not responded to standard treatments, including ovarian cancer and Merk…

This study is testing a new drug called FF-10832, both by itself and combined with an existing immunotherapy (pembrolizumab), for people with advanced lung or bladder cancer. The main goals are to find a safe dose and see if the treatment can help control the cancer. It is for pa…